Fernando Cordera
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Fernando Cordera has a total of 1000 co-authors. Here are the top co-authors by number of shared publications:
- Rodrigo Arrangoiz
Fox Chase Cancer Center, Philadelphia, PA, USA
13 shared publications Eduardo Moreno
9 shared publicationsEnrique Luque-De-León
ABC Medical Center, Mexico
6 shared publicationsDavid Caba
5 shared publicationsManuel Muñoz
5 shared publications- Jorge Sanchez-Garcia
Intermountain Health Salt Lake City Utah USA
4 shared publications
Latest Publications
- Open Access
- 1 July 2023
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 108, 108482
Breast implant-associated anaplastic large cell lymphoma presenting as a breast mass: A case report and literature review
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare neoplasm most frequently associated with textured implant placement. The classic presentation consists of a persistent periprosthetic seroma. Implant removal and individualized adjuvant treatment are potentially curative interventions. Most BIA-ALCL present with a seroma, not with a breast and/or axillary mass. Knowledge of this presentation and how to manage it allows an adequate diagnosis, and appropriate treatment with excellent results. A 44-year-old woman presented with a 3-month history of a right breast mass located in the lower medial quadrant, with associated right axillary lymphadenopathy. Medical history was significant for a mastoplasty with textured implants 15 years before the onset of her symptoms. Imaging studies and histological analysis helped to confirm the diagnosis of BIA-ALCL. A bilateral capsulectomy was performed and adjuvant chemotherapy and immunotherapy were administered. With these interventions, the patient had complete resolution of her symptoms, good cosmetic results, and absence of tumor activity detectable by positron emission tomography with fluorodeoxyglucose (PET-CT FDG) at a 2.5-year follow-up. This case describes an atypical presentation of BIA-ALCL as a breast mass, as well as lymph node and bone marrow involvement. Knowledge of the different presentation modalities of this pathology is necessary for a correct diagnosis and treatment. Through a multidisciplinary approach, adequate treatment was given with excellent results. Anaplastic large cell lymphoma associated with breast implants is a clinicopathological entity still little known in some medical fields. A variety of presentations must be considered, and high clinical suspicion must be maintained in patients with a history of textured breast implant placement to optimize diagnosis and avoid delays in treatment.
- 1 July 2023
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 108, 108482
Open AccessBreast implant-associated anaplastic large cell lymphoma presenting as a breast mass: A case report and literature review
Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare neoplasm most frequently associated with textured implant placement. The classic presentation consists of a persistent periprosthetic seroma. Implant removal and individualized adjuvant treatment are potentially curative interventions. Most BIA-ALCL present with a seroma, not with a breast and/or axillary mass. Knowledge of this presentation and how to manage it allows an adequate diagnosis, and appropriate treatment with excellent results. A 44-year-old woman presented with a 3-month history of a right breast mass located in the lower medial quadrant, with associated right axillary lymphadenopathy. Medical history was significant for a mastoplasty with textured implants 15 years before the onset of her symptoms. Imaging studies and histological analysis helped to confirm the diagnosis of BIA-ALCL. A bilateral capsulectomy was performed and adjuvant chemotherapy and immunotherapy were administered. With these interventions, the patient had complete resolution of her symptoms, good cosmetic results, and absence of tumor activity detectable by positron emission tomography with fluorodeoxyglucose (PET-CT FDG) at a 2.5-year follow-up. This case describes an atypical presentation of BIA-ALCL as a breast mass, as well as lymph node and bone marrow involvement. Knowledge of the different presentation modalities of this pathology is necessary for a correct diagnosis and treatment. Through a multidisciplinary approach, adequate treatment was given with excellent results. Anaplastic large cell lymphoma associated with breast implants is a clinicopathological entity still little known in some medical fields. A variety of presentations must be considered, and high clinical suspicion must be maintained in patients with a history of textured breast implant placement to optimize diagnosis and avoid delays in treatment.
- Open Access
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Effects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 24 May 2022
- Published by Elsevier in The Lancet Global Health
- Vol. 10 (7) , e1003-e1011
Open AccessEffects of hospital facilities on patient outcomes after cancer surgery: an international, prospective, observational study
- 23 May 2019
- Published by Remedy Publications, LLC in American Journal of Otolaryngology and Head and Neck Surgery
- Vol. 2 (5)
Increase Cancer Risk in Patients with Primary Hyperparathyroidism
- 23 May 2019
- Published by Remedy Publications, LLC in American Journal of Otolaryngology and Head and Neck Surgery
- Vol. 2 (5)
Increase Cancer Risk in Patients with Primary Hyperparathyroidism
- Open Access
- 1 January 2019
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 65 (C) , 271-274
Laparoscopic resection of gastric schwannoma
Introduction: Gastric schwannomas are an extremely rare presentation of mesenchymal tumors originating from Schwann cells, accounting for 0.2% of all gastric tumors. Patients are usually asymptomatic, so these tumors are frequently detected incidentally. Presentation of case: 68-year old male patient found to have a 5 cm mass in the lesser curvature of the stomach. After a careful preoperative evaluation, complete laparoscopic resection was performed. Pathology review confirmed a completely resected gastric Schwannoma. The patient’s recovery was uneventful. At a one-year follow-up he remains asymptomatic and with no evidence of disease. Discussion: We present the uncommon case of a gastric schwannoma that was appropriately treated with a laparoscopic approach and present a current literature review focusing on diagnostic and treatment methods of these rare tumors. Conclusion: Schwannomas should be included in the differential diagnosis of gastric tumors and can be appropriately treated with a laparoscopic approach. Highlights:
- 1 January 2019
- Published by Wolters Kluwer Health in International Journal of Surgery Case Reports
- Vol. 65 (C) , 271-274
Open AccessLaparoscopic resection of gastric schwannoma
Introduction: Gastric schwannomas are an extremely rare presentation of mesenchymal tumors originating from Schwann cells, accounting for 0.2% of all gastric tumors. Patients are usually asymptomatic, so these tumors are frequently detected incidentally. Presentation of case: 68-year old male patient found to have a 5 cm mass in the lesser curvature of the stomach. After a careful preoperative evaluation, complete laparoscopic resection was performed. Pathology review confirmed a completely resected gastric Schwannoma. The patient’s recovery was uneventful. At a one-year follow-up he remains asymptomatic and with no evidence of disease. Discussion: We present the uncommon case of a gastric schwannoma that was appropriately treated with a laparoscopic approach and present a current literature review focusing on diagnostic and treatment methods of these rare tumors. Conclusion: Schwannomas should be included in the differential diagnosis of gastric tumors and can be appropriately treated with a laparoscopic approach. Highlights:
- Open Access
- 1 January 2019
- Published by ScopeMed in International Journal of Medical Reviews and Case Reports
The Appropriate Diagnosis of Primary Hyperparathyroidism.
- 1 January 2019
- Published by ScopeMed in International Journal of Medical Reviews and Case Reports
Open AccessThe Appropriate Diagnosis of Primary Hyperparathyroidism.
- 21 November 2018
- Published by Remedy Publications, LLC in American Journal of Otolaryngology and Head and Neck Surgery
- Vol. 1 (6)
Case Report and Literature Review of Medullary Thyroid Carcinoma
- 21 November 2018
- Published by Remedy Publications, LLC in American Journal of Otolaryngology and Head and Neck Surgery
- Vol. 1 (6)
Case Report and Literature Review of Medullary Thyroid Carcinoma
- Open Access
- 30 April 2018
- Published by ClinMed International Library in International Journal of Surgery Research and Practice
- Vol. 5 (1)
Does Vitamin D Deficiency Cause Primary Hyperparathyroidism?
- 30 April 2018
- Published by ClinMed International Library in International Journal of Surgery Research and Practice
- Vol. 5 (1)
Open AccessDoes Vitamin D Deficiency Cause Primary Hyperparathyroidism?
- Open Access
- 1 January 2018
- Published by Open Access Text Pvt, Ltd. in Cancer Reports and Reviews
- Vol. 2 (3)
Oral Tongue Cancer: Literature Review and Current Management
OA Text is an independent open-access scientific publisher showcases innovative research and ideas aimed at improving health by linking research and practice to the benefit of society.
- 1 January 2018
- Published by Open Access Text Pvt, Ltd. in Cancer Reports and Reviews
- Vol. 2 (3)
Open AccessOral Tongue Cancer: Literature Review and Current Management
OA Text is an independent open-access scientific publisher showcases innovative research and ideas aimed at improving health by linking research and practice to the benefit of society.
- Open Access
- 3 May 2017
- Published by Science Publishing Group in Journal of Surgery
- Vol. 5 (3) , 37-42
Management of Complications Related to Laparoscopic Adjustable Silicone Gastric Band
Laparoscopic adjustable silicone gastric band (LASGB) is frequently used to treat morbidly obese patients worldwide. Complications related to this procedure have increased as the follow-up interval of these patients has increased. Treatment of these complications often includes removal of the silicone band. Herein we report our experience with silicone gastric band removal, discuss the different treatment alternatives, and present a management algorithm. A retrospective review of complications related to LASGB was made from June of 2003 to April of 2010 (eight patients). Techniques of band extraction are discussed and a management algorithm is presented. The mean Body Mass Index at the time of LASGB placement was 39.45 (Range 34.2 - 42.8). The median patient’s age at the time of LASGB was of 32.6 years (range: 13 to 50 years). The average durability of the silicone band after laparoscopic placement was 67.8 months (range: 6 to 120 months). In three patients (37.5%) the LASGB had perforated the gastric wall and was therefore extracted using a transgastric approach (laparoscopic in two patients and by laparotomy in one patient). In five patients the silicone band had not perforated the stomach and was therefore removed laparoscopically without entering the stomach. The weight was recovered in 37.5% of the patients during follow-up. Management of patients with complications related to LASGB placement must be individualized and should address both the band related complication as well as the obesity problem. Laparoscopic trans-gastric band extraction is ideal when the LASGB has eroded into the stomach and endoscopic extraction is not feasible.
- 3 May 2017
- Published by Science Publishing Group in Journal of Surgery
- Vol. 5 (3) , 37-42
Open AccessManagement of Complications Related to Laparoscopic Adjustable Silicone Gastric Band
Laparoscopic adjustable silicone gastric band (LASGB) is frequently used to treat morbidly obese patients worldwide. Complications related to this procedure have increased as the follow-up interval of these patients has increased. Treatment of these complications often includes removal of the silicone band. Herein we report our experience with silicone gastric band removal, discuss the different treatment alternatives, and present a management algorithm. A retrospective review of complications related to LASGB was made from June of 2003 to April of 2010 (eight patients). Techniques of band extraction are discussed and a management algorithm is presented. The mean Body Mass Index at the time of LASGB placement was 39.45 (Range 34.2 - 42.8). The median patient’s age at the time of LASGB was of 32.6 years (range: 13 to 50 years). The average durability of the silicone band after laparoscopic placement was 67.8 months (range: 6 to 120 months). In three patients (37.5%) the LASGB had perforated the gastric wall and was therefore extracted using a transgastric approach (laparoscopic in two patients and by laparotomy in one patient). In five patients the silicone band had not perforated the stomach and was therefore removed laparoscopically without entering the stomach. The weight was recovered in 37.5% of the patients during follow-up. Management of patients with complications related to LASGB placement must be individualized and should address both the band related complication as well as the obesity problem. Laparoscopic trans-gastric band extraction is ideal when the LASGB has eroded into the stomach and endoscopic extraction is not feasible.
- Open Access
- 27 March 2017
- Published by Science Publishing Group in Journal of Cancer Treatment and Research
- Vol. 5 (3) , 51-61
Current Understanding and Management of Parathyroid Carcinoma
Parathyroid adenomas are a very common endocrine entity, whereas parathyroid carcinomas (PC) are extremely rare. With an estimated incidence of 0.015 per 100,000 population and an estimated prevalence of 0.005% in the United States, parathyroid cancer is one of the rarest of all human malignancies. PC is an extremely rare cause of primary hyperparathyroidism (PHPT). Men and women are equally affected, usually in the fourth or fifth decade of life. The exact etiology has not been identified, but mutations in the CDC73 gene appear to have a critical role in its pathogenesis. The morbidity and mortality of PC is secondary to the hypercalcemia resulting from tumor overproduction of PTH. The primary management objectives are complete removal of the cancer and prevention of recurrences. This review will talk about the epidemiology, etiology, clinical manifestations, and management of PC.
- 27 March 2017
- Published by Science Publishing Group in Journal of Cancer Treatment and Research
- Vol. 5 (3) , 51-61
Open AccessCurrent Understanding and Management of Parathyroid Carcinoma
Parathyroid adenomas are a very common endocrine entity, whereas parathyroid carcinomas (PC) are extremely rare. With an estimated incidence of 0.015 per 100,000 population and an estimated prevalence of 0.005% in the United States, parathyroid cancer is one of the rarest of all human malignancies. PC is an extremely rare cause of primary hyperparathyroidism (PHPT). Men and women are equally affected, usually in the fourth or fifth decade of life. The exact etiology has not been identified, but mutations in the CDC73 gene appear to have a critical role in its pathogenesis. The morbidity and mortality of PC is secondary to the hypercalcemia resulting from tumor overproduction of PTH. The primary management objectives are complete removal of the cancer and prevention of recurrences. This review will talk about the epidemiology, etiology, clinical manifestations, and management of PC.